<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Assertio Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Assertio Therapeutics, Inc.

    Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Arthur J. Higgins
    • FOUNDED
      1995
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Adverum Biotechnologies, Inc.

    Adverum Biotechnologies, Inc.

    Adverum is a clinical-stage gene therapy company targeting unmet medical need in o...

    Adverum is a clinical-stage gene therapy compan...

    Filing Type:    PU
    Otonomy, Inc.

    Otonomy, Inc.

    Otonomy is a biopharmaceutical company dedicated to the development of innovative ...

    Otonomy is a biopharmaceutical company dedicate...

    Filing Type:    PU
    Oracle Health, Inc.

    Oracle Health, Inc.

    Oracle Health is developing a Digital Health Insertable (Under The Skin) Cardiac D...

    Oracle Health is developing a Digital Health In...

    Amount Raised:    $182,002.00
    Fundraising Status:    EC
    Filing Type:    CF
    Mylan N.V.

    Mylan N.V.

    Mylan is a global pharmaceutical company committed to setting new standards in hea...

    Mylan is a global pharmaceutical company commit...

    Filing Type:    PU
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    Miragen Therapeutics, Inc.

    Miragen Therapeutics, Inc.

    miRagen Therapeutics, Inc., is a clinical stage biopharmaceutical company discover...

    miRagen Therapeutics, Inc., is a clinical stage...

    Filing Type:    PU
    Acorda Therapeutics, Inc.

    Acorda Therapeutics, Inc.

    Acorda Therapeutics is a biotechnology company focused on developing therapies tha...

    Acorda Therapeutics is a biotechnology company ...

    Filing Type:    PU
    Quadrant Biosciences Inc

    Quadrant Biosciences Inc

    Quadrant Biosciences is an epigenetic diagnostics company with a focus on the earl...

    Quadrant Biosciences is an epigenetic diagnosti...

    Filing Type:    RA
    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.